A BILL 
To amend the Controlled Substances Act to clarify how con-
trolled substance analogues that are imported or offered 
for import are to be regulated, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
3
(a) SHORT TITLE.—This Act may be cited as the 
4
‘‘Stop the Importation and Manufacturing of Synthetic 
5
Analogues Act of 2019’’ or ‘‘SIMSA’’. 
6
19:24 Nov 10, 2019
H4963
2 
•HR 4963 IH
(b) TABLE OF CONTENTS.—The table of contents of 
1
this Act is as follows: 
2
Sec. 1. Short title; table of contents. 
Sec. 2. Establishment of schedule A. 
Sec. 3. Temporary and permanent scheduling of schedule A substances. 
Sec. 4. Penalties. 
Sec. 5. False labeling of schedule A controlled substances. 
Sec. 6. Registration requirements for importers and exporters of schedule A 
substances. 
Sec. 7. Additional conforming amendments. 
Sec. 8. Sentencing review. 
Sec. 9. Rules of construction. 
SEC. 2. ESTABLISHMENT OF SCHEDULE A. 
3
Section 202 of the Controlled Substances Act (21 
4
U.S.C. 812) is amended— 
5
(1) in subsection (a), by striking ‘‘five schedules 
6
of controlled substances, to be known as schedules I, 
7
II, III, IV, and V’’ and inserting ‘‘six schedules of 
8
controlled substances, to be known as schedules I, 
9
II, III, IV, V, and A’’; 
10
(2) in subsection (b), by adding at the end the 
11
following: 
12
‘‘(6) SCHEDULE A.— 
13
‘‘(A) IN GENERAL.—The drug or substance— 
14
‘‘(i) is or has been imported, or is offered 
15
for import, into the United States; 
16
‘‘(ii) has— 
17
‘‘(I) a chemical structure that is sub-
18
stantially similar to the chemical structure 
19
19:24 Nov 10, 2019
H4963
3 
•HR 4963 IH
of a controlled substance in schedule I, II, 
1
III, IV, or V; and 
2
‘‘(II) an actual or predicted stimulant, 
3
depressant, or hallucinogenic effect on the 
4
central nervous system that is substantially 
5
similar to or greater than the stimulant, 
6
depressant, or hallucinogenic effect on the 
7
central nervous system of a controlled sub-
8
stance in schedule I, II, III, IV, or V; and 
9
‘‘(iii) is not— 
10
‘‘(I) listed or otherwise included in 
11
any other schedule in this section or by 
12
regulation of the Attorney General; and 
13
‘‘(II) with respect to a particular per-
14
son, subject to an exemption that is in ef-
15
fect for investigational use, for that person, 
16
under section 505 of the Federal Food, 
17
Drug, and Cosmetic Act (21 U.S.C. 355) 
18
to the extent conduct with respect to such 
19
substance is pursuant to such exemption. 
20
‘‘(B) PREDICTED STIMULANT, DEPRESSANT, OR 
21
HALLUCINOGENIC
EFFECT.—For purposes of this 
22
paragraph, a predicted stimulant, depressant, or hal-
23
lucinogenic effect on the central nervous system may 
24
be based on— 
25
19:24 Nov 10, 2019
H4963
4 
•HR 4963 IH
‘‘(i)(I) the chemical structure; and 
1
‘‘(II)(aa) the structure activity relation-
2
ships; or 
3
‘‘(bb) binding receptor assays and other 
4
relevant scientific information about the sub-
5
stance; 
6
‘‘(ii)(I) the current or relative potential for 
7
abuse of the substance; and 
8
‘‘(II) the clandestine importation, manu-
9
facture, or distribution, or diversion from legiti-
10
mate channels, of the substance; or 
11
‘‘(iii) the capacity of the substance to 
12
cause a state of dependence, including physical 
13
or psychological dependence that is similar to or 
14
greater than that of a controlled substance in 
15
schedule I, II, III, IV, or V.’’; and 
16
(3) in subsection (c)— 
17
(A) in the matter preceding schedule I, by 
18
striking ‘‘IV, and V’’ and inserting ‘‘IV, V, and 
19
A’’; and 
20
(B) by adding at the end the following: 
21
‘‘SCHEDULE A 
22
‘‘Any substance temporarily or permanently sched-
23
uled by the Attorney General in accordance with section 
24
201(k).’’. 
25
19:24 Nov 10, 2019
H4963
5 
•HR 4963 IH
SEC. 3. TEMPORARY AND PERMANENT SCHEDULING OF 
1
SCHEDULE A SUBSTANCES. 
2
Section 201 of the Controlled Substances Act (21 
3
U.S.C. 811) is amended by adding at the end the fol-
4
lowing: 
5
‘‘(k) TEMPORARY AND PERMANENT SCHEDULING OF 
6
SCHEDULE A SUBSTANCES.— 
7
‘‘(1) IN GENERAL.—The Attorney General may 
8
issue a temporary order adding a drug or substance 
9
to schedule A if the Attorney General finds that— 
10
‘‘(A) the drug or other substance satisfies 
11
the criteria for being considered a schedule A 
12
substance; and 
13
‘‘(B) adding such drug or substance to 
14
schedule A will assist in preventing abuse of the 
15
drug or other substance. 
16
‘‘(2) DURATION OF TEMPORARY SCHEDULING 
17
ORDER.—A temporary scheduling order issued under 
18
paragraph (1) shall— 
19
‘‘(A) not take effect until 30 days after the 
20
date of the publication by the Attorney General 
21
of a notice in the Federal Register of the inten-
22
tion to issue such order and the grounds upon 
23
which such order is to be issued; and 
24
‘‘(B) expire not later than 5 years after 
25
the date on which the order becomes effective, 
26
19:24 Nov 10, 2019
H4963
6 
•HR 4963 IH
except that the Attorney General may, during 
1
the pendency of proceedings under paragraph 
2
(5), extend the temporary scheduling order for 
3
up to 180 days. 
4
‘‘(3) EFFECT
OF
ISSUANCE
OF
PERMANENT 
5
SCHEDULING
ORDER.—A 
temporary 
scheduling 
6
order issued under paragraph (1) shall be vacated 
7
upon the issuance of a permanent order issued 
8
under paragraph (5) with regard to the same sub-
9
stance, or upon the subsequent issuance of any 
10
scheduling order under this section. 
11
‘‘(4) LIMITATION
ON
JUDICIAL
REVIEW.—A 
12
temporary scheduling order issued under paragraph 
13
(1) shall not be subject to judicial review. 
14
‘‘(5) PERMANENT SCHEDULING ORDER.— 
15
‘‘(A) IN GENERAL.—Except as provided in 
16
subparagraph (B), not earlier than 3 years 
17
after the date on which the Attorney General 
18
issues an order temporarily scheduling a drug 
19
or substance under this subsection, the Attor-
20
ney General may, by rule, issue a permanent 
21
order adding the drug or other substance to 
22
schedule A if such drug or substance satisfies 
23
the criteria for being considered a schedule A 
24
substance. 
25
19:24 Nov 10, 2019
H4963
7 
•HR 4963 IH
‘‘(B) LIMITATION.—If the Secretary of 
1
Health and Human Services has determined, 
2
based on relevant scientific studies and nec-
3
essary data requested by the Secretary of 
4
Health and Human Services and gathered by 
5
the Attorney General, that a drug or other sub-
6
stance that has been temporarily placed in 
7
schedule A does not have sufficient potential for 
8
abuse to warrant control in any schedule, and 
9
provides written notice of such determination to 
10
the Attorney General, the Attorney General— 
11
‘‘(i) may not issue a permanent sched-
12
uling order under subparagraph (A); and 
13
‘‘(ii) not later than 30 days after the 
14
date on which the Attorney General re-
15
ceives such notice, shall issue an order im-
16
mediately 
terminating 
the 
temporary 
17
scheduling order for the drug or other sub-
18
stance. 
19
‘‘(6) NOTICE TO HHS.—Before initiating pro-
20
ceedings under paragraph (1), the Attorney General 
21
shall transmit notice of a temporary order proposed 
22
to be issued to the Secretary of Health and Human 
23
Services. In issuing an order under paragraph (1), 
24
the Attorney General shall take into consideration 
25
19:24 Nov 10, 2019
H4963
8 
•HR 4963 IH
any comments submitted by the Secretary of Health 
1
and Human Services in response to a notice trans-
2
mitted pursuant to this paragraph.’’. 
3
SEC. 4. PENALTIES. 
4
Section 1010 of the Controlled Substances Import 
5
and Export Act (21 U.S.C. 960) is amended— 
6
(1) in subsection (a), by inserting ‘‘or a drug or 
7
substance in schedule A’’ after ‘‘controlled sub-
8
stance’’ each place it appears; and 
9
(2) in subsection (b), by adding at the end the 
10
following: 
11
‘‘(8) In the case of a violation under subsection (a) 
12
involving a controlled substance in schedule A, the person 
13
committing such violation shall be sentenced to a term of 
14
imprisonment of not more than 20 years and if death or 
15
serious bodily injury results from the use of such sub-
16
stance shall be sentenced to a term of imprisonment for 
17
any term of years or for life, a fine not to exceed the great-
18
er of that authorized in accordance with the provisions of 
19
title 18, United States Code, or $1,000,000 if the defend-
20
ant is an individual or $5,000,000 if the defendant is other 
21
than an individual, or both. If any person commits such 
22
a violation after a prior conviction for a felony drug of-
23
fense has become final, such person shall be sentenced to 
24
a term of imprisonment of not more than 30 years and 
25
19:24 Nov 10, 2019
H4963
9 
•HR 4963 IH
if death or serious bodily injury results from the use of 
1
such substance shall be sentenced to a term of imprison-
2
ment for any term of years or for life, a fine not to exceed 
3
the greater of twice that authorized in accordance with 
4
the provisions of title 18, United States Code, or 
5
$2,000,000 if the defendant is an individual or 
6
$10,000,000 if the defendant is other than an individual, 
7
or both. Notwithstanding section 3583 of title 18, United 
8
States Code, any sentence imposing a term of imprison-
9
ment under this paragraph shall, in the absence of such 
10
a prior conviction, impose a term of supervised release of 
11
not less than 3 years in addition to such term of imprison-
12
ment and shall, if there was such a prior conviction, im-
13
pose a term of supervised release of not less than 6 years 
14
in addition to such term of imprisonment. Notwith-
15
standing the prior sentence, and notwithstanding any 
16
other provision of law, the court shall not place on proba-
17
tion or suspend the sentence of any person sentenced 
18
under the provisions of this paragraph which provide for 
19
a mandatory term of imprisonment if death or serious 
20
bodily injury results.’’. 
21
19:24 Nov 10, 2019
H4963
10 
•HR 4963 IH
SEC. 5. FALSE LABELING OF SCHEDULE A CONTROLLED 
1
SUBSTANCES. 
2
(a) IN GENERAL.—Section 305 of the Controlled 
3
Substances Act (21 U.S.C. 825) is amended by adding at 
4
the end the following: 
5
‘‘(f) FALSE
LABELING
OF
SCHEDULE
A CON-
6
TROLLED SUBSTANCES.— 
7
‘‘(1) It shall be unlawful to import or export, 
8
with intent to manufacture, distribute, or dispense, 
9
a schedule A substance or product containing a 
10
schedule A substance, unless the substance or prod-
11
uct bears a label clearly identifying a schedule A 
12
substance or product containing a schedule A sub-
13
stance by the nomenclature used by the Inter-
14
national Union of Pure and Applied Chemistry 
15
(IUPAC). 
16
‘‘(2)(A) A product described in subparagraph 
17
(B) is exempt from the International Union of Pure 
18
and Applied Chemistry nomenclature requirement of 
19
this subsection if such product is labeled in the man-
20
ner required under the Federal Food, Drug, and 
21
Cosmetic Act. 
22
‘‘(B) A product is described in this subpara-
23
graph if the product— 
24
19:24 Nov 10, 2019
H4963
11 
•HR 4963 IH
‘‘(i) is the subject of an approved applica-
1
tion as described in section 505(b) or (j) of the 
2
Federal Food, Drug, and Cosmetic Act; or 
3
‘‘(ii) is exempt from the provisions of sec-
4
tion 505 of such Act relating to new drugs be-
5
cause— 
6
‘‘(I) it is intended solely for investiga-
7
tional use as described in section 505(i) of 
8
such Act; and 
9
‘‘(II) such product is being used ex-
10
clusively for purposes of a clinical trial 
11
that is the subject of an effective investiga-
12
tional new drug application.’’. 
13
(b) PENALTIES.—Section 402 of the Controlled Sub-
14
stances Act (21 U.S.C. 842) is amended— 
15
(1) in subsection (a)— 
16
(A) in paragraph (16), by striking ‘‘or’’ at 
17
the end; 
18
(B) by redesignating paragraph (17) as 
19
paragraph (18); and 
20
(C) by inserting after paragraph (16) the 
21
following: 
22
‘‘(17) to violate section 305(f); or’’; and 
23
(2) in subsection (c)— 
24
(A) in paragraph (1)— 
25
19:24 Nov 10, 2019
H4963
12 
•HR 4963 IH
(i) in subparagraph (B)(i), by striking 
1
‘‘(17)’’ and inserting ‘‘(18)’’; and 
2
(ii) in subparagraph (C), by inserting 
3
‘‘or (17)’’ after ‘‘paragraph (16)’’ each 
4
place it appears; and 
5
(B) in paragraph (2)(D), by striking 
6
‘‘(17)’’ and inserting ‘‘(18)’’. 
7
SEC. 6. REGISTRATION REQUIREMENTS FOR IMPORTERS 
8
AND 
EXPORTERS 
OF 
SCHEDULE 
A 
SUB-
9
STANCES. 
10
Section 1008 of the Controlled Substances Import 
11
and Export Act (21 U.S.C. 958) is amended by adding 
12
at the end the following: 
13
‘‘(j)(1) The Attorney General shall register an appli-
14
cant to import or export a schedule A substance if— 
15
‘‘(A) the applicant demonstrates that the sched-
16
ule A substance will be used for research, analytical, 
17
or industrial purposes approved by the Attorney 
18
General; and 
19
‘‘(B) the Attorney General determines that such 
20
registration is consistent with the public interest and 
21
with the United States obligations under inter-
22
national treaties, conventions, or protocols in effect 
23
on the date of enactment of this subsection. 
24
19:24 Nov 10, 2019
H4963
13 
•HR 4963 IH
‘‘(2) In determining the public interest under para-
1
graph (1)(B), the Attorney General shall consider— 
2
‘‘(A) maintenance of effective controls against 
3
diversion of particular controlled substances and any 
4
controlled substance in schedule A compounded 
5
therefrom into other than legitimate medical, sci-
6
entific, research, or industrial channels, by limiting 
7
the importation and bulk manufacture of such con-
8
trolled substances to a number of establishments 
9
which can produce an adequate and uninterrupted 
10
supply of these substances under adequately com-
11
petitive conditions for legitimate medical, scientific, 
12
research, and industrial purposes; 
13
‘‘(B) compliance with applicable State and local 
14
law; 
15
‘‘(C) promotion of technical advances in the art 
16
of manufacturing substances described in subpara-
17
graph (A) and the development of new substances; 
18
‘‘(D) prior conviction record of applicant under 
19
Federal and State laws relating to the importation, 
20
manufacture, distribution, or dispensing of sub-
21
stances described in subparagraph (A); 
22
‘‘(E) past experience in the importation and 
23
manufacture of controlled substances, and the exist-
24
19:24 Nov 10, 2019
H4963
14 
•HR 4963 IH
ence in the establishment of effective control against 
1
diversion; and 
2
‘‘(F) such other factors as may be relevant to 
3
and consistent with the public health and safety. 
4
‘‘(3) If an applicant is registered to import or export 
5
a controlled substance in schedule I or II under subsection 
6
(a), the applicant shall not be required to apply for a sepa-
7
rate registration under this subsection.’’. 
8
SEC. 7. ADDITIONAL CONFORMING AMENDMENTS. 
9
The Controlled Substances Import and Export Act 
10
(21 U.S.C. 951 et seq.) is amended— 
11
(1) in section 1002(a) (21 U.S.C. 952(a))— 
12
(A) in the matter preceding paragraph (1), 
13
by inserting ‘‘or drug or substance in schedule 
14
A’’ after ‘‘schedule I or II’’; and 
15
(B) in paragraph (2), by inserting ‘‘or 
16
drug or substances in schedule A’’ after ‘‘sched-
17
ule I or II’’; 
18
(2) in section 1003 (21 U.S.C. 953)— 
19
(A) in subsection (c), in the matter pre-
20
ceding paragraph (1), by inserting ‘‘or drug or 
21
substance in schedule A’’ after ‘‘schedule I or 
22
II’’; and 
23
19:24 Nov 10, 2019
H4963
15 
•HR 4963 IH
(B) in subsection (d), by inserting ‘‘or 
1
drug or substance in schedule A’’ after ‘‘sched-
2
ule I or II’’; 
3
(3) in section 1004(1) (21 U.S.C. 954(1)), in 
4
the matter preceding subparagraph (A), by inserting 
5
‘‘or drug or substance in schedule A’’ after ‘‘sched-
6
ule I’’; 
7
(4) in section 1005 (21 U.S.C. 955), by insert-
8
ing ‘‘or drug or substance in schedule A’’ after 
9
‘‘schedule I or II’’; and 
10
(5) in section 1009(a) (21 U.S.C. 959(a)), by 
11
inserting ‘‘or drug or substance in schedule A’’ after 
12
‘‘schedule I or II’’. 
13
SEC. 8. SENTENCING REVIEW. 
14
(a) COVERED OFFENSE DEFINED.—In this section, 
15
the term ‘‘covered offense’’ means an offense involving a 
16
schedule A substance for which the penalty was estab-
17
lished under section 4 or 5 of this Act. 
18
(b) SENTENCING REVIEW.— 
19
(1) PETITION FOR REVIEW.—If a schedule A 
20
substance that is temporarily or permanently sched-
21
uled under section 201(k) of the Controlled Sub-
22
stances Act, as added by this Act, is subsequently 
23
descheduled or rescheduled on a schedule with lower 
24
penalties, any individual convicted of a covered of-
25
19:24 Nov 10, 2019
H4963
16 
•HR 4963 IH
fense involving such schedule A substance who is 
1
awaiting sentencing or is still serving a term of im-
2
prisonment for such covered offense on the date of 
3
the descheduling or rescheduling may petition the 
4
court that imposed the sentence for a sentencing re-
5
duction hearing for such covered offense. 
6
(2) SENTENCING REVIEW.—Not later than 30 
7
days after the date on which a petition is filed under 
8
paragraph (1), the court shall conduct a sentencing 
9
reduction hearing and may modify the sentence of 
10
the petitioner as if the descheduling or rescheduling 
11
described in paragraph (1) had been in effect on the 
12
date the covered offense was committed. 
13
SEC. 9. RULES OF CONSTRUCTION. 
14
Nothing in this Act, or the amendments made by this 
15
Act, may be construed to limit— 
16
(1) the prosecution of offenses involving con-
17
trolled substance analogues under the Controlled 
18
Substances Act (21 U.S.C. 801 et seq.); or 
19
(2) the authority of the Attorney General to 
20
temporarily or permanently schedule, reschedule, or 
21
decontrol controlled substances under provisions of 
22
section 201 of the Controlled Substances Act (21 
23
19:24 Nov 10, 2019
H4963
17 
•HR 4963 IH
U.S.C. 811) that are in effect on the day before the 
1
date of enactment of this Act. 
2
Æ 
19:24 Nov 10, 2019
H4963
